ReMind UK were delighted to host the most recent European Alzheimer’s Disease Consortum (EADC) conference in Bath on 5th & 6th November at the Bath Royal Literacy & Scientific Institution. Dr Tomas Welsh, ReMind UK’s Research & Medical Director, was among the welcoming speakers.
Who are EADC?
The European Alzheimer Disease Consortium is a registered Scientific Society, with an overarching aim to create a network of centers of excellence and to come together collaboratively, in order that the scientific understanding of Alzheimer’s disease is advanced, and to develop ways by which the primary and secondary symptoms of the disease can be diagnosed, prevented, delayed and treated.
Attendees from ReMind UK included (left to right) Dr Tomas Welsh, Research & Medical Director, Dr Cathy Wernham, Senior Clinical Research Fellow & Memory Clinic Physician, Ella Venn, UKDTN Research Nurse, Research Psycologists, Victoria Greer and Hannah Oram and Dr Aron Jarvis, Research Fellow & Rating Lead. ReMind UK’s Chief Executive Officer, Melissa Hillier, also joined over the course of the weekend.
The conference had a packed agenda with speakers from across Europe. We were delighted that Professor Cath Mummery was able to share the work of the UK Dementia Trials Network, which we are a part of as well as Dr Aron Jarvis discussing his findings from his PhD which he recently completed at ReMind UK.
Melissa Hillier
Melissa continues, “The EADC, which meets twice a year in various locations across Europe, brings together those working in research and clinical practice enabling a sharing of knowledge alongside building lasting connections with others working in similar fields so that everyone can better support people affected by dementia.”
The conference consisted of lectures and presentations, including a Junior Researcher Lecture from Dr Aron Jarvis who presented the findings from his recent PhD on Psychological Distress as a Prognostic Marker in People with Dementia.
Overall, the conference served as a timely reminder that Alzheimer's research is a global endeavour.
Ella Venn - UKDTN Research Nurse, ReMind UK
ReMind UK’s UK Dementia Trials Netowork Research Nurse, Ella Venn reflects, “The EADC meeting in Bath was a positive and welcoming experience. It was, first and foremost, an inspiring platform to explore the variety of research being conducted across the group. Notable presentations include learning about new, portable ultra-low-field MRI scanners and investigations into the potential effects of particular lifestyle factors on brain atrophy, both of which, encouraged consideration of how the delivery of dementia clinical trials might be remodelled in the future. It was also particularly intriguing to hear about how the EADC supports young researchers through their RRFS exchanges abroad, and how they might like to develop this programme in years to come. Overall, the conference served as a timely reminder that Alzheimer’s research is a global endeavour. Regardless of their location across the world, EADC members and colleagues are all working together towards the common goal of better understating the disease.”
The next EADC conference is due to take place 15th & 16th April 2027 in Bratislava, Slovakia.
More news & views

Smoking & the risk of dementia
This month’s brain health blog looks at the link between smoking and dementia risk, and why quitting could be an important step towards protecting your brain for the future.

What is the future of dementia research?
In July, London hosted the Alzheimer’s Association International Conference (AAIC), an annual conference dedicated to advancing dementia science and clinical practice.

Living with Alzheimer’s – Derek McCaig’s story
An Alzheimer’s diagnosis can bring uncertainty. What will life look like now? For Derek McCaig and his wife Sue, adapting to Alzheimer’s has meant making some changes but it has also meant continuing to stay active, social and involved in the things they enjoy.